PCT & Support

Tamoxifen 10 mg Androlex

Androlex

40,00

In Stock (100 available)

Tamoxifen 10 mg Androlex (10 mg) — This Androlex formulation delivers a Selective Estrogen Receptor Modulator (SERM) that is a cornerstone of post-cycle therapy (PCT…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

Tamoxifen 10 mg Androlex — tamoxifen from Androlex at 10 mg. SERM with tissue-selective agonist/antagonist activity. Blocks breast-tissue estrogen receptors (gyno prevention) while acting as agonist at hypothalamus (driving LH/FSH for PCT).

Key Benefits

  • SERM — selectively blocks estrogen at the breast tissue (no gyno)
  • Does not lower systemic E2 (unlike AIs) — safer for lipids
  • PCT workhorse — stimulates LH/FSH release via hypothalamic feedback
  • Available as generic — reliably priced worldwide
  • Standard dose 20 mg/day; PCT protocols 20–40 mg/day
  • Each unit dosed at 10 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: on-cycle 10–20 mg/day for gyno prevention; PCT 20–40 mg/day for 4 weeks. Some researchers taper PCT: 40/20/20/10. Nolva alone is a valid PCT for mild-to-moderate cycles.

How It Works

Selective estrogen receptor modulator (SERM). Antagonises the estrogen receptor in breast tissue (prevents gyno) while acting as a partial agonist at the hypothalamus (stimulates LH/FSH release) and liver (maintains favourable lipids).

Pharmacokinetics

Plasma half-life approximately 5–7 days (active metabolite 14 days). Once-daily dosing. Long action tail — consider when planning PCT timeline.

Potential Side Effects

Mood effects possible (a minority of users experience depression/lethargy). Vision changes at high dose are rare but documented. No lipid hit. DVT risk in susceptible individuals on long runs.

Cycle & Stacking Guide

On-cycle: 10–20 mg/day if prone to gyno. PCT: 20–40 mg/day for 4 weeks, starting 14 days after last long-ester injection (or 3–5 days after short-ester). Often paired with Clomid for stronger LH stimulation.

Manufacturer Notes

Androlex is a Moldovan producer focused on injectable AAS at standard concentrations. Each vial carries a batch-traceable code verifiable through their distributor network.

Storage & Handling

Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Tamoxifen 10 mg Androlex”

Your email address will not be published. Required fields are marked *

Tamoxifen

Physical & Chemical Properties for Research Purposes
Chemical structure of Tamoxifen (C26H29NO) for laboratory analysis
2D structural representation · PubChem CID 2733526 ↗
Chemical Identity
# CAS Registry Number 10540-29-1
Σ IUPAC Name (Z)-2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine
F Molecular Formula C26H29NO
M Molecular Weight 371.51 g/mol
SMILES CC/C(=C(C1=CC=CC=C1)C2=CC=C(OCCN(C)C)C=C2)C3=CC=CC=C3
InChIKey NKANXQFJJICGDU-QPLCGJKRSA-N
Melting Point 97-98 °C
Solubility Practically insoluble in water; soluble in ethanol and methanol
Biological Half-life 5-7 days (oral)
PubChem CID 2733526 ↗
Pharmacological Profile
Aromatization None
Hepatotoxicity Low
Known trade names: Nolvadex, Tamoxen, Tamofen

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.